AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 616905942 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 30
Study 34479850 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported sleep hours
Number of subjects: 221
Study 34479850 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia Severity Index (ISI) score
Number of subjects: 221
Study 34479850 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression scores
Number of subjects: 221
Study 34479850 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia severity
Number of subjects: 221
Study 34479850 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing speed
Number of subjects: 221
Study 32305457 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation services, shared patient registry, web-based social determinants of health platform
Number of subjects: 0
Study 33338485 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with long set configuration (LSC/LI-RE)
Number of subjects: 10
Study 33338485 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with short set configuration (SSC/LI-RE)
Number of subjects: 10
Study 33338485 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 10
Study 32919416 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seropositive (1,044 participants, 55.4%)
Number of subjects: 1855
Study 2000318910 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (3 million KIU)
Number of subjects: 54
Study 2000318910 — intervention group
Group type: COMPARATOR
Intervention: Control (non-treated with aprotinin)
Number of subjects: 54
Study 35232475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 1 day/week
Number of subjects: 0
Study 35232475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 2 days/week
Number of subjects: 0
Study 35232475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 3 days/week
Number of subjects: 0
Study 35232475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT)
Number of subjects: 0
Study 36207530 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension digital therapeutics app with home BP monitoring (HBPM)
Number of subjects: 0
Study 36207530 — intervention group
Group type: COMPARATOR
Intervention: Control group under physician management using HBPM and lifestyle modifications
Number of subjects: 0
Study 34599495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention plus usual care
Number of subjects: 227
Study 34599495 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 227
Study 35414714 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic bedroom lighting (DD-N lighting)
Number of subjects: 30
Study 35414714 — intervention group
Group type: COMPARATOR
Intervention: Standard lighting system
Number of subjects: 30
Study 33492457 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma intact fibroblast growth factor 23 (iFGF23) levels in XLH patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: COMPARATOR
Intervention: Plasma intact fibroblast growth factor 23 (iFGF23) levels in FS patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate levels in XLH patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: COMPARATOR
Intervention: Phosphate levels in FS patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: EXPERIMENTAL
Intervention: iPTH levels in XLH patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: EXPERIMENTAL
Intervention: TmP/GFR in XLH patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: COMPARATOR
Intervention: TmP/GFR in FS patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR in XLH patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: COMPARATOR
Intervention: eGFR in FS patients
Number of subjects: 18
Study 33492457 — intervention group
Group type: COMPARATOR
Intervention: Hypercalciuria in FS patients
Number of subjects: 18
Study 32700844 — intervention group
Group type: EXPERIMENTAL
Intervention: Amomum cardamom plant extract, 3 h exposure
Number of subjects: 7
Study 32700844 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma mangga plant extract, 3 h exposure
Number of subjects: 7
Study 32700844 — intervention group
Group type: EXPERIMENTAL
Intervention: Various medicinal plant extracts, 3 h exposure
Number of subjects: 7
Study 34304346 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted antibiotic prophylaxis based on rectal swab results
Number of subjects: 140
Study 34304346 — intervention group
Group type: COMPARATOR
Intervention: Routine ciprofloxacin prophylaxis
Number of subjects: 140
Study 34042572 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: propofol, remifentanil, and desflurane
Number of subjects: 21
Study 34042572 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: dexmedetomidine, remifentanil, and desflurane
Number of subjects: 21
Study 34042572 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: remifentanil and desflurane
Number of subjects: 21
Study 33727034 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous regulation of tracheal cuff pressure using a pneumatic device
Number of subjects: 434
Study 33727034 — intervention group
Group type: COMPARATOR
Intervention: Routine care (manual assessment three times daily using a portable manometer)
Number of subjects: 434
Study 33081736 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted diabetes self-management education intervention delivered by peer educators
Number of subjects: 48
Study 35503024 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioral Therapy (ICBT) for 7 weeks
Number of subjects: 52
Study 35503024 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 52
Study 32009486 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-g oral collagen hydrolysate (CH) daily for 4 weeks
Number of subjects: 36
Study 32009486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32974739 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinoplasty in patients with facial asymmetry
Number of subjects: 60
Study 32974739 — intervention group
Group type: COMPARATOR
Intervention: Rhinoplasty in patients with symmetric faces
Number of subjects: 60
Study 32623370 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage, irrigation and fibrinolytic therapy (DRIFT)
Number of subjects: 77
Study 32623370 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 77
Study 33863383 — intervention group
Group type: EXPERIMENTAL
Intervention: MSC treatment
Number of subjects: 22
Study 33863383 — intervention group
Group type: COMPARATOR
Intervention: rituximab
Number of subjects: 22
Study 32520439 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical medication review (CMR)
Number of subjects: 588
Study 32520439 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study 34011328 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Community Psychiatric Treatment (ICPT)
Number of subjects: 93
Study 34011328 — intervention group
Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 93
Study 33032474 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodefen Plus® (synbiotic)
Number of subjects: 151
Study 33032474 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 151
Study 36398114 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Vibration (LIV) - 0.4 g at 30 Hz for 10 min/day
Number of subjects: 20
Study 36398114 — intervention group
Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 20
Study 32840458 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 39
Study 32840458 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping following Manual Therapy (KTMT)
Number of subjects: 39
Study 34058071 — intervention group
Group type: EXPERIMENTAL
Intervention: GDC-0334 (25 mg starting dose)
Number of subjects: 0
Study 33475533 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% concentration of povidone iodine
Number of subjects: 80
Study 33475533 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% concentration of povidone iodine
Number of subjects: 80
Study 33475533 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% concentration of povidone iodine
Number of subjects: 80
Study 33475533 — intervention group
Group type: COMPARATOR
Intervention: Saline-only controls
Number of subjects: 80
Study 35536231 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeying through Dementia intervention (n=191)
Number of subjects: 480
Study 35536231 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=197)
Number of subjects: 480
Study 35536231 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeying through Dementia intervention
Number of subjects: 480
Study 35536231 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 480
Study 33475753 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnea (OSA) diagnosed through polysomnography
Number of subjects: 4607
Study 33475753 — intervention group
Group type: EXPERIMENTAL
Intervention: No OSA management or treatment
Number of subjects: 4607
Study 33475753 — intervention group
Group type: EXPERIMENTAL
Intervention: OSA exposure time interval (short term, middle term, long term)
Number of subjects: 4607
Study 36380290 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for Appropriate Care and Treatment (InterACT) trial
Number of subjects: 0
Study 35806937 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antiplatelet treatment
Number of subjects: 60
Study 35806937 — intervention group
Group type: COMPARATOR
Intervention: Natural wound healing (control group)
Number of subjects: 60
Study 32332636 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with basic western medicine (BWC)
Number of subjects: 150
Study 32332636 — intervention group
Group type: COMPARATOR
Intervention: Basic western medicine (BWC)
Number of subjects: 150
Study 32332636 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (sham EA) with basic western medicine (BWC)
Number of subjects: 150
Study 34392795 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint‐induced movement therapy (CIMT) and neurostimulation paired with intensive, goal‐directed therapy
Number of subjects: 45
Study 34392795 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 45
Study 34168025 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions evaluated in randomised controlled trials
Number of subjects: 129
Study 34168025 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallstone disease specific patient-reported outcome measures (PROMs)
Number of subjects: 129
Study 34168025 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies
Number of subjects: 129
Study 34168025 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary qualitative research
Number of subjects: 129
Study 32986748 — intervention group
Group type: EXPERIMENTAL
Intervention: Amaranth bread (150g containing 70% amaranth and 30% chickpea)
Number of subjects: 100
Study 32986748 — intervention group
Group type: COMPARATOR
Intervention: Maize bread (150g containing processed maize)
Number of subjects: 100
Study 35617987 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex bacterial PCR group
Number of subjects: 208
Study 35617987 — intervention group
Group type: COMPARATOR
Intervention: Conventional microbiology control group
Number of subjects: 208
Study 35617987 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 208
Study 34137329 — intervention group
Group type: EXPERIMENTAL
Intervention: CT + SES
Number of subjects: 90
Study 34137329 — intervention group
Group type: EXPERIMENTAL
Intervention: CT + NMES
Number of subjects: 90
Study 34137329 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 90
Study 32005160 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL ropivacaine (7.5 mg/mL)
Number of subjects: 60
Study 32005160 — intervention group
Group type: COMPARATOR
Intervention: 20 mL saline (placebo)
Number of subjects: 60
Study 35043250 — intervention group
Group type: EXPERIMENTAL
Intervention: AVJA + CRT-D
Number of subjects: 26
Study 35043250 — intervention group
Group type: COMPARATOR
Intervention: CRT-D only
Number of subjects: 26
Study 35043250 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 26
Study 32959591 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with Yuyin pill
Number of subjects: 60
Study 32959591 — intervention group
Group type: COMPARATOR
Intervention: Yuyin pill alone
Number of subjects: 60
Study 36055440 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (LDLPFC)
Number of subjects: 31
Study 36055440 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to right dorsolateral prefrontal cortex (RDLPFC)
Number of subjects: 31
Study 36055440 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study 33423966 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with capecitabine for 6 months
Number of subjects: 0
Study 33423966 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiochemotherapy
Number of subjects: 0
Study 33423966 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiation therapy
Number of subjects: 0
Study 33423966 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 33423966 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiochemotherapy
Number of subjects: 0
Study 35767935 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aloe vera gel
Number of subjects: 120
Study 35767935 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 120
Study 34099659 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1) combined with chemotherapies
Number of subjects: 2616
Study 34099659 — intervention group
Group type: EXPERIMENTAL
Intervention: High polygenic risk score (PRS) for lifetime risk of hypothyroidism
Number of subjects: 2616
Study 34099659 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 2616
Study 32417893 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 100
Study 32417893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 100
Study 34070396 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-GI diet
Number of subjects: 20
Study 34070396 — intervention group
Group type: COMPARATOR
Intervention: Usual childcare diet (Control)
Number of subjects: 20
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at Diskus (PIFD)
Number of subjects: 0
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at HandiHaler (PIFHH)
Number of subjects: 0
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at zero resistance
Number of subjects: 0
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeatability limit for PIFD
Number of subjects: 0
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeatability limit for PIFHH
Number of subjects: 0
Study 32343967 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling relationship between PIFD and PIFHH
Number of subjects: 0
Study 34656781 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization in external rotation (ER)
Number of subjects: 198
Study 34656781 — intervention group
Group type: COMPARATOR
Intervention: Immobilization in internal rotation (IR)
Number of subjects: 198
Study 34730887 — intervention group
Group type: EXPERIMENTAL
Intervention: SHP block with bupivacaine injection
Number of subjects: 115
Study 34730887 — intervention group
Group type: COMPARATOR
Intervention: Control group with saline injection
Number of subjects: 115
Study 32887591 — intervention group
Group type: EXPERIMENTAL
Intervention: Namaste Care Family program
Number of subjects: 231
Study 32887591 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 231
Study 34964679 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization + Physical Therapy
Number of subjects: 56
Study 34964679 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 56
Study 34881911 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy for PTSD (DBT-PTSD)
Number of subjects: 93
Study 34881911 — intervention group
Group type: COMPARATOR
Intervention: Cognitive processing therapy (CPT)
Number of subjects: 93
Study 34881911 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT-PTSD
Number of subjects: 93
Study 34881911 — intervention group
Group type: COMPARATOR
Intervention: CPT
Number of subjects: 93
Study 34799265 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-supported vestibular rehabilitation program (30-min a day, 5 sessions per week, 15 sessions total for 3 weeks)
Number of subjects: 32
Study 34799265 — intervention group
Group type: COMPARATOR
Intervention: Conventional vestibular rehabilitation program (30-min a day, 5 sessions per week, 15 sessions total for 3 weeks)
Number of subjects: 32
Study 34928359 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-based CCRT (100 mg/m2 every 3 weeks for 3 cycles)
Number of subjects: 402
Study 34928359 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedaplatin-based CCRT (100 mg/m2 every 3 weeks for 3 cycles)
Number of subjects: 402
Study 34928359 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-based CCRT
Number of subjects: 402
Study 32150478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 404
Study 32150478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Endoscopic Mucosal Resection (CS-EMR)
Number of subjects: 404
Study 32150478 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR)
Number of subjects: 404
Study 36416543 — intervention group
Group type: EXPERIMENTAL
Intervention: EE + DNG
Number of subjects: 59
Study 36416543 — intervention group
Group type: EXPERIMENTAL
Intervention: EV + DNG
Number of subjects: 59
Study 36416543 — intervention group
Group type: COMPARATOR
Intervention: DNG only
Number of subjects: 59
Study 36416543 — intervention group
Group type: COMPARATOR
Intervention: EE + DNG vs EV + DNG
Number of subjects: 59
Study 34373988 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based exercise training (n = 60)
Number of subjects: 120
Study 34373988 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 60)
Number of subjects: 120
Study 32618037 — intervention group
Group type: EXPERIMENTAL
Intervention: T. chebula 250 mg
Number of subjects: 60
Study 32618037 — intervention group
Group type: EXPERIMENTAL
Intervention: T. chebula 500 mg
Number of subjects: 60
Study 32618037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34173133 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas (intervention)
Number of subjects: 194
Study 34173133 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 194
Study 32857471 — intervention group
Group type: EXPERIMENTAL
Intervention: SPL 25 mg/day plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63
Study 32857471 — intervention group
Group type: EXPERIMENTAL
Intervention: SPL 50 mg/day plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63
Study 32857471 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63
Study 35293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids for 30 days before RAI ablation (G2)
Number of subjects: 85
Study 35293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids for 30 days after RAI ablation (G3)
Number of subjects: 85
Study 35293348 — intervention group
Group type: COMPARATOR
Intervention: RAI ablation only (G1)
Number of subjects: 85
Study 35293348 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 85
Study 34333734 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT program (After Deployment, Adaptive Parenting Tools)
Number of subjects: 181
Study 34468726 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 0
Study 34468726 — intervention group
Group type: EXPERIMENTAL
Intervention: MIR4453HG
Number of subjects: 0
Study 34468726 — intervention group
Group type: EXPERIMENTAL
Intervention: KCNK17
Number of subjects: 0
Study 34468726 — intervention group
Group type: COMPARATOR
Intervention: Cataract
Number of subjects: 0
Study 34468726 — intervention group
Group type: COMPARATOR
Intervention: Comparative analysis on European population
Number of subjects: 0
Study 33749220 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% sodium hexametaphosphate (SHMP) added to a 3% hydrogen peroxide bleaching gel applied for 6 hours per night for 2 weeks
Number of subjects: 24
Study 33749220 — intervention group
Group type: COMPARATOR
Intervention: 3% hydrogen peroxide bleaching gel (control group)
Number of subjects: 24
Study 32301128 — intervention group
Group type: EXPERIMENTAL
Intervention: Online HOPE intervention
Number of subjects: 0
Study 32301128 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35709685 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)‐R enantiomer (RPQ)
Number of subjects: 36
Study 35709685 — intervention group
Group type: EXPERIMENTAL
Intervention: (+)‐S enantiomer (SPQ)
Number of subjects: 36
Study 35709685 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic PQ (RSPQ)
Number of subjects: 36
Study 35452415 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibular osteotomy (FO) with joint debridement
Number of subjects: 88
Study 35452415 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic debridement (control)
Number of subjects: 88
Study 34159469 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Assisted Cycle Ergometer (AACE)
Number of subjects: 55
Study 34159469 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 55